Mineralocorticoid Receptor Antagonists Modulate Galectin-3 and Interleukin-33/ST2 Signaling in Left Ventricular Systolic Dysfunction After Acute Myocardial Infarction-Reference-Cited by-同舟云学术

Mineralocorticoid Receptor Antagonists Modulate Galectin-3 and Interleukin-33/ST2 Signaling in Left Ventricular Systolic Dysfunction After Acute Myocardial Infarction

Published:2015-01 Issue:1 Volume:3 Page:50-58
ISSN:2213-1779
Container-title:JACC: Heart Failure
language:en
Short-container-title:JACC: Heart Failure

Author:

Lax Antonio,Sanchez-Mas Jesus,Asensio-Lopez Maria C.,Fernandez-Del Palacio Maria J.,Caballero Luis,Garrido Iris P.,Pastor-Perez Francisco J.,Januzzi James L.,Pascual-Figal Domingo A.

Funder

Fundación Séneca

Ministerio de Sanidad

National Network of Investigation in Cardiovascular Diseases

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference42 articles.

1. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators;Pitt;N Engl J Med,1999

2. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction;Pitt;N Engl J Med,2003

3. Eplerenone in patients with systolic heart failure and mild symptoms;Zannad;N Engl J Med,2011